PELP1-KD in Hep3B cells led to a notable decrease in tumor volume and weights compared with control Hep3B xenografts, indicating that PELP1-KD hinders the progression of HCC tumors (Fig. 5A and D). Here, PELP1 is linked to neoplasm.